"The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
GRANISETRON - ORAL
COMMON BRAND NAME(S): Kytril
USES: This medication is used to prevent nausea and vomiting due to cancer drug treatment (chemotherapy) and radiation therapy. It works by blocking one of the body's chemicals (serotonin) that causes vomiting.
HOW TO USE: Take this medication by mouth. It is important to follow your doctor's instructions for the timing of each dose. If you have any questions, consult your doctor or pharmacist.
Inform your doctor if your condition persists or worsens.
Additional Kytril Information
Kytril - User Reviews
Kytril User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.